CRYSTALLINE FORMS OF 4-[6-(6-METHANESULFONYL-2-METHYLPYRIDIN-3-YLAMINO)-5-METHOXY-PYRIMIDIN-4-YLOXY]-PIPERIDINE-1-CARBOXYLIC ACID ISOPROPYL ESTER

摘要

The present invention is directed to a novel crystalline forms of 4-[6-(6- methanesulfonyl-2-methyl-pyhdin-3-ylamino)-5-methoxy-pyhmidin-4-yloxy]- piperidine-1 -carboxylic acid isopropyl ester, pharmaceutical compositions containing said crystalline form and the use of said crystalline forms in the treatment of metabolic related disorders. The present invention is further directed to processes for the preparation of the crystalline forms of 4-[6-(6- methanesulfonyl-2-methyl-pyhdin-3-ylamino)-5-methoxy-pyhmidin-4-yloxy]- piperidine-1 -carboxylic acid isopropyl ester.